This strategy is particularly effective in the context of PCa, where inhibition of the IRE1a branch of the UPR significantly impairs tumour growth and activation of c‐MYC signalling (Sheng et al, 2019), an important feature of ADT resistance (Bernard et al, 2003). Here, ERN1 is linked to posterior cortical atrophy.